ES397911A1 - Procedimiento para la obtencion de derivados de piperidina. - Google Patents

Procedimiento para la obtencion de derivados de piperidina.

Info

Publication number
ES397911A1
ES397911A1 ES397911A ES397911A ES397911A1 ES 397911 A1 ES397911 A1 ES 397911A1 ES 397911 A ES397911 A ES 397911A ES 397911 A ES397911 A ES 397911A ES 397911 A1 ES397911 A1 ES 397911A1
Authority
ES
Spain
Prior art keywords
compounds
translation
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES397911A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5968670A external-priority patent/GB1356117A/en
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES397911A1 publication Critical patent/ES397911A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES397911A 1970-12-16 1971-12-13 Procedimiento para la obtencion de derivados de piperidina. Expired ES397911A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5968670A GB1356117A (en) 1970-12-16 1970-12-16 1-3-cyano-3,3-diphenylpropyl-4-phenylpiperidine-4-carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
ES397911A1 true ES397911A1 (es) 1975-04-16

Family

ID=10484227

Family Applications (4)

Application Number Title Priority Date Filing Date
ES397912A Expired ES397912A1 (es) 1970-12-16 1971-12-13 Procedimiento para la obtencion de derivados de piperidina.
ES397911A Expired ES397911A1 (es) 1970-12-16 1971-12-13 Procedimiento para la obtencion de derivados de piperidina.
ES400479A Expired ES400479A1 (es) 1970-12-16 1972-03-06 Procedimiento para la obtencion de derivados de piperidina con actividad anti-diarreica.
ES400478A Expired ES400478A1 (es) 1970-12-16 1972-03-06 Procedimiento para la obtencion de derivados de piperidina con actividad anti-diarreica.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES397912A Expired ES397912A1 (es) 1970-12-16 1971-12-13 Procedimiento para la obtencion de derivados de piperidina.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES400479A Expired ES400479A1 (es) 1970-12-16 1972-03-06 Procedimiento para la obtencion de derivados de piperidina con actividad anti-diarreica.
ES400478A Expired ES400478A1 (es) 1970-12-16 1972-03-06 Procedimiento para la obtencion de derivados de piperidina con actividad anti-diarreica.

Country Status (9)

Country Link
JP (1) JPS5542996B1 (enExample)
CA (1) CA918157A (enExample)
CY (1) CY925A (enExample)
DK (2) DK136037B (enExample)
ES (4) ES397912A1 (enExample)
IE (2) IE35890B1 (enExample)
SE (2) SE370543B (enExample)
YU (2) YU34991B (enExample)
ZA (2) ZA718380B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115962U (ja) * 1984-06-30 1986-01-30 儀介 野沢 豚用飼槽

Also Published As

Publication number Publication date
JPS5542996B1 (enExample) 1980-11-04
ES400479A1 (es) 1975-01-16
IE35889B1 (en) 1976-06-23
ES397912A1 (es) 1975-04-16
DK130966B (da) 1975-05-12
CY925A (en) 1977-12-23
SE370542B (enExample) 1974-10-21
IE35890L (en) 1972-06-16
CA918157A (en) 1973-01-02
IE35890B1 (en) 1976-06-23
YU34991B (en) 1980-06-30
SE370543B (enExample) 1974-10-21
DK136037C (enExample) 1978-01-02
YU248778A (en) 1979-12-31
DK130966C (enExample) 1975-10-06
ZA718380B (en) 1973-02-28
YU34990B (en) 1980-06-30
YU248678A (en) 1979-12-31
ZA718379B (en) 1973-02-28
ES400478A1 (es) 1975-01-01
DK136037B (da) 1977-08-01
IE35889L (en) 1972-06-16

Similar Documents

Publication Publication Date Title
Lecoutey et al. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
Varty et al. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists
Dooley et al. Alteration of central alpha2-and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin
McCracken et al. Two novel σ receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity
Cao et al. Use of NK1 knockout mice to analyze substance P-induced edema formation
DasGupta et al. Separation of toxin and hemagglutinin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration
Mollica et al. Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
Leo et al. Intrathecal resiniferatoxin modulates TRPV1 in DRG neurons and reduces TNF‐induced pain‐related behavior
Gebbia et al. Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor
ES397911A1 (es) Procedimiento para la obtencion de derivados de piperidina.
Albert Neurokinin antagonists and their potential role in treating depression and other stress disorders
ES438315A1 (es) Un procedimiento para preparar compuestos de decahidroiso- quinolina.
Alanine et al. 1-Benzyloxy-4, 5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists
Woolley et al. Differentiation between receptors for serotonin and tryptamine by means of the exquisite specificity of antimetabolites
Berger et al. Pentamidine analogs as inhibitors of [3H] MK-801 and [3H] ifenprodil binding to rat brain NMDA receptors
Hansen-Schwartz et al. Endothelium-dependent relaxant responses to selective 5-HT1B/1D receptor agonists in the isolated middle cerebral artery of the rat
Wiernik Lenalidomide in lymphomas and chronic lymphocytic leukemia
Björk et al. (S)-UH-301 antagonizes (R)-8-OH-DPAT-indiiced cardiovascular effects in the rat
Abatematteo et al. Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect
Grider et al. Physiological role of neuropeptide Y in the regulation of the ascending phase of the peristaltic reflex
Haley Chemical differentiation of desoxyephedrine from other sympathomimetic amines
Deligia et al. Design of novel 3, 6-diazabicyclo [3.1. 1] heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors
Salazar‐Bookaman et al. Antagonism by imidazoline–type drugs of muscarinic and other receptors in the guinea‐pig ileum
ES372620A1 (es) Un procedimiento para la preparacion de benzodiacepinas.
Nomura Central β-adrenergic receptors for blood pressure regulation in spontaneously hypertensive rats